SCHEMBL4157346

SCHEMBL4157346

COc1ccccc1CNC(=O)N(C)c1ccc(SC(F)(F)F)cc1F

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HPGD P15428 7/20 0.47
NLRP3 Q96P20 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
ALDH1A1 P00352 3/20 0.43
KMT2A Q03164 2/20 0.43
HTT P42858 2/20 0.43
GAA P10253 2/20 0.43
PKM P14618 1/20 0.43
TSHR P16473 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MEN1 O00255 1/20 0.41
POLB P06746 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
HDAC1 Q13547 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4144739 0.83 MAPT (0.46) HPGDSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL4155698 0.82 PTPRZ1 (0.44) HPGDALDH1A1KMT2AHTTGAA
SCHEMBL4145579 0.81 ROCK2 (0.48) HPGDSMN1; SMN2ALDH1A1KMT2AHTT
SCHEMBL4144820 0.81 PTPRZ1 (0.35) SMN1; SMN2HTTGAATSHR
SCHEMBL4142022 0.79 PTPRZ1 (0.37) SMN1; SMN2ALDH1A1HTTTSHR
SCHEMBL13774526 0.79 MCHR1 (0.37) HPGDSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL4150041 0.79 ALDH1A1 (0.43) SMN1; SMN2NPC1RAB9AALDH1A1KMT2A
SCHEMBL4150851 0.78 PTPRZ1 (0.36) ALDH1A1HTTGAATSHRL3MBTL1
SCHEMBL4166771 0.78 RXFP1 (0.36) HPGDNLRP3NPC1KMT2AGAA
SCHEMBL4145099 0.78 KMT2A (0.34) HPGDALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 HPGD 4852/4885NLRP3 937/4885SMN1; SMN2 2011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.